TAIYABA MAJIDI: Open Payments
NPI 1497489215 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 2 payments from 1 company in 2025. Trend: 2023 $0 · 2024 $406 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $296 |
Products named: REZDIFFRA.
Industry payments across CA — which companies pay providers there.
